Cg Oncology, Inc. · NASDAQ:CGON
James B. Tananbaum's stake in Cg Oncology, Inc. fell to 4.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
James B. Tananbaum's stake in Cg Oncology, Inc. fell to 4.90%, 4,306,174 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 4,306,174
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Foresite Capital Fund V, L.P. | 1.20% | 1,079,050 |
| Foresite Capital Management V, LLC | 1.20% | 1,079,050 |
| Foresite Capital Opportunity Fund V, L.P. | 1.00% | 857,550 |
| Foresite Capital Opportunity Management V, LLC | 1.00% | 857,550 |
| Foresite Capital Fund VI LP | 2.70% | 2,369,574 |
| Foresite Capital Management VI LLC | 2.70% | 2,369,574 |
| James B. Tananbaum | 4.90% | 4,306,174 |
Source
Related
- Cg Oncology, Inc.
- Foresite Capital Fund V, L.P.
- Cg Oncology, Inc. shareholders
- Form 4 · Post Leonard E · Oct 19, 2026
- Form 4 · Post Leonard E · Sep 17, 2026
- Form 4 · Post Leonard E · Aug 18, 2026
- Schedule 13G/A · Rtw Investments, LP · Aug 14, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026